• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2018 Fiscal Year Final Research Report

Genetic testing in pheochromocytomas/ paragangliomas (including tentative study NGS)in Japan.

Research Project

  • PDF
Project/Area Number 16K08961
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Laboratory medicine
Research InstitutionUniversity of Tsukuba

Principal Investigator

kawakami yasushi  筑波大学, 医学医療系, 教授 (70234028)

Co-Investigator(Kenkyū-buntansha) 竹越 一博  筑波大学, 医学医療系, 教授 (40261804)
Project Period (FY) 2016-04-01 – 2019-03-31
Keywords褐色細胞腫 / 次世代シークエンサー / 遺伝子パネル
Outline of Final Research Achievements

Introduction: Great progress has been achieved in the fields, especially genetics in pheochromocytomas/ paragangliomas . Major aim of this study is to investigate genetic back ground in Japan.Results: 1) We have carried out genetic testing in 398 cases in Japan. In 340 index cases, we found 130 cases whose genetic mutations are positive and summarized herein : SDHB 54 cases, SDHD 32 cases, VHL 20 cases, RET 8 cases, TMEM 127 7 cases, MAX 6 cases.Consequently, notably high degree (130/340=38.2%) of patients carry genetic mutation, similar to those of previous reports from USA and Europe.
2) Growing evidence suggest that mutation of SDHB is highly associated with abdominal paraganglioma and the following distant metastasis.
In the present study, analysis of blood taken from 57 cases of malignant pheochromocytomas in Japanese subjects led to the identification of 17 SDHB mutations(20/57=35.1%).

Free Research Field

内分泌・代謝

Academic Significance and Societal Importance of the Research Achievements

筑波大学で解析を施行したpheochromocytoma/ paraganglioma の2007年から2019年4月までの結果は以下の通りである。1)398例解析済みである。発端者340例中変異陽性は130例で,変異陽性率は38.2%(130/340)(内訳:SDHB.54例,SDHD.32例,VHL.20例,SDHC.2例,SDHA.1例,RET.8例,TMEM1127.7例,MAX.6例)。2)SDHB変異陽性患者49例中54例が腹部パラガングリオ-マが初発(90.7%)であり、悪性化した例が20例(20/54=37.0%)であった。

URL: 

Published: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi